02.03.2014 Views

National Survey of Research Commercialisation - Australian ...

National Survey of Research Commercialisation - Australian ...

National Survey of Research Commercialisation - Australian ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Inventor involvement in licensing<br />

EXECUTIVE SUMMARY<br />

Inventor involvement appears to be an important element <strong>of</strong> strategies employed by<br />

universities, medical research institutes and CSIRO to manage their commercial licensing<br />

activities:<br />

In 73% <strong>of</strong> cases, inventors were either extremely involved or very involved in licensing<br />

activities.<br />

In only 5% <strong>of</strong> cases were inventors uninvolved in licensing activities.<br />

Start-up companies<br />

In total, 47 new start-up companies were formed in Year 2000 as a result <strong>of</strong> research<br />

conducted within the respondent institutions — <strong>of</strong> these, 91% had their headquarters<br />

in Australia.<br />

Of the 102 start-up companies that were reported to have been formed at any time<br />

as the result <strong>of</strong> research conducted within the respondent institutions, 101 were still<br />

operational at the end <strong>of</strong> Year 2000.<br />

Respondent institutions held equity in 63% <strong>of</strong> their start-up companies at the end <strong>of</strong><br />

Year 2000.<br />

COUNTRY COMPARISONS<br />

The <strong>National</strong> <strong>Survey</strong> <strong>of</strong> <strong>Research</strong> <strong>Commercialisation</strong> generated information about the<br />

extent <strong>of</strong> research commercialisation activity occurring in universities and medical<br />

research institutes in Australia.<br />

An analysis was undertaken to compare that information with information about<br />

commercial activities occurring in similar institutions in the USA and Canada.<br />

The indicators that were used to undertake the country comparisons were:<br />

number <strong>of</strong> US patents issued in Year 2000;<br />

number <strong>of</strong> licences executed in Year 2000;<br />

amount <strong>of</strong> adjusted gross income from licences in Year 2000; and<br />

number <strong>of</strong> start-up companies that were formed in Year 2000.<br />

Comparisons were made on the basis <strong>of</strong> ratios that express the value <strong>of</strong> each <strong>of</strong> these<br />

indicators relative to research expenditure and to gross domestic product (GDP),<br />

respectively.<br />

All financial amounts used in the calculation <strong>of</strong> these ratios are expressed in US$, on<br />

the basis <strong>of</strong> adjustments that were made to ensure purchasing power parity between<br />

amounts for the three countries.<br />

The amounts <strong>of</strong> GDP were also adjusted to account for differences in response rates<br />

<strong>of</strong> institutions in the three countries. This was not necessary in the case <strong>of</strong> research<br />

expenditure, since the expenditure used in the calculation <strong>of</strong> ratios for the comparisons<br />

was only that <strong>of</strong> the respondent institutions in the three countries.<br />

9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!